{"id":"W1975988459","doi":"10.1016/s1499-2671(09)33265-7","title":"Two years of treatment with liraglutide, a human GLP-1 analogue, offers sustained and greater reduction with HbA1c, FPG, PPG and weight compared with glimepiride, with lower glycaemic risk, in patients with type 2 diabetes: LEAD-3 extension study","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Liraglutide; Glimepiride; Medicine; Tolerability; Type 2 diabetes; Weight loss; Blood pressure; Internal medicine; Diabetes mellitus; Canagliflozin; Urology; Endocrinology; Adverse effect; Obesity","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002381161,0.002471693,0.004199844,0.0005179316,0.001093327,0.001532882,0.0009401077,0.002669897,0.004039232],"category_scores_gemma":[0.001505712,0.001002644,0.005128145,0.0008424637,0.001427319,0.001811409,0.0007879538,0.004894427,0.001148367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001075908,"about_ca_system_score_gemma":0.001971412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007321538,"about_ca_topic_score_gemma":0.01007663,"domain_scores_codex":[0.9991197,0.0003022061,0.00005508534,0.0001331953,0.0000738563,0.0003160124],"domain_scores_gemma":[0.9982027,0.0002404502,0.0002095051,0.0002583808,0.0001196561,0.0009692619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.96868,0.01649179,0.004027658,0.0001096886,0.0008928732,0.0000716645,0.00009397886,0.0001922394,0.001786545,0.00001982274,0.0005621944,0.007071583],"study_design_scores_gemma":[0.6562554,0.3054236,0.03351739,0.00003763148,0.002061616,0.0001412264,0.0001047675,0.000287316,0.0009959557,0.0001224845,0.0009955075,0.00005700046],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958718,0.001013717,0.0001633634,0.0002718985,0.0001078167,0.0004118684,0.001311502,0.00005873895,0.0007893624],"genre_scores_gemma":[0.9918847,0.0009796685,0.0003819828,0.0007179079,0.0003187143,0.0005759833,0.002654237,0.00003138133,0.002455579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007321538,"threshold_uncertainty_score":0.01455784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008421805482413619,"score_gpt":0.2155480412962324,"score_spread":0.2071262358138188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}